Orthofix (OFIX) director John Henneman buys 5,000 shares at $12.26

Rhea-AI Filing Summary

Orthofix Medical Inc. director John B. Henneman III made an open-market purchase of 5,000 shares of common stock at $12.259 per share. Following this transaction, he holds 90,809 shares directly, which the footnote explains includes 48,347 deferred stock units and 2,103 shares acquired under Orthofix's Stock Purchase Plan.

Insider Trade Summary

Net Buyer: 5,000 shares ($61,295)

Net Buy 1 txn

Insider HENNEMAN JOHN B III

Role null

Bought 5,000 shs ($61K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	5,000	$12.259	$61K

Holdings After Transaction: Common Stock — 90,809 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 5,000 shares Purchase price: $12.259 per share Total holdings after trade: 90,809 shares +3 more

6 metrics

Shares purchased 5,000 shares Open-market purchase of common stock

Purchase price $12.259 per share Price paid in Form 4 transaction

Total holdings after trade 90,809 shares Direct ownership following purchase

Deferred stock units included 48,347 units Part of total reported holdings

SPP shares included 2,103 shares Acquired under Orthofix's Stock Purchase Plan

Net buy shares 5,000 shares Net change in position per transactionSummary

Key Terms

deferred stock units, Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)

4 terms

deferred stock units financial

"Includes 48,347 previously reported deferred stock units and an aggregate of 2,103 shares"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Stock Purchase Plan financial

"shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025"

Rule 16b-3(b)(5) regulatory

"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"

Section 16(b) regulatory

"share acquisitions under the plan are exempt from Section 16(b)."

A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HENNEMAN JOHN B III

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		P		5,000	A	$12.259	90,809(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 48,347 previously reported deferred stock units and an aggregate of 2,103 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

	/s/ J. Andres Cedron, Attorney-in-fact	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Orthofix (OFIX) report in this Form 4?

Orthofix reported that director John B. Henneman III made an open-market purchase of 5,000 shares of common stock. The shares were bought at $12.259 each, increasing his directly held position in Orthofix Medical Inc.

At what price did the Orthofix (OFIX) director buy shares?

Director John B. Henneman III purchased 5,000 Orthofix common shares at $12.259 per share. This open-market transaction was recorded on the Form 4 as a standard purchase in the company’s common stock.

How many Orthofix (OFIX) shares does the director hold after the trade?

After the 5,000-share purchase, John B. Henneman III holds 90,809 Orthofix shares directly. The total includes 48,347 deferred stock units and 2,103 shares acquired previously under Orthofix’s Stock Purchase Plan, according to the footnote.

What are the deferred stock units mentioned in the Orthofix (OFIX) filing?

The filing notes that 48,347 of the director’s reported holdings are deferred stock units. These represent previously reported units that convert into shares under plan terms, and are counted within his total of 90,809 Orthofix shares.

What is Orthofix's Stock Purchase Plan referenced in the Form 4?

The footnote explains that Orthofix’s Stock Purchase Plan is a "Stock Purchase Plan" under Rule 16b-3(b)(5). It notes 2,103 shares were acquired under this plan and that such acquisitions are exempt from Section 16(b) short-swing profit rules.

Was this Orthofix (OFIX) insider transaction a buy or a sell?

This insider transaction was a buy. The Form 4 classifies it as an open-market purchase of 5,000 Orthofix common shares, with the transaction code "P" and direction listed as a net buy of 5,000 shares.